ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,871, issued on June 10, was assigned to University of Copenhagen (Copenhagen, Denmark) and GLYCODISPLAY APS (Copenhagen, Denmark).

"Lysosomal enzymes modified by cell based glycoengineering" was invented by Claus Kristensen (Bronshoj, Denmark), Weihua Tian (Hvidovre, Denmark), Henrik Clausen (Copenhagen, Denmark), Zhang Yang (Gentofte, Denmark) and Sergey Vakhrushev (Nyborg, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to lysosomal enzymes modified by use of cell based methods, a compositions comprising a modified lysosomal enzyme, as well as methods for producing a modified lysosomal enzyme and therapeutic us...